Clinical Research in NSCLC
Irinotecan
& NSCLC - Recent MEDLINE Abstracts
Irinotecan
& NSCLC - Clinical Trials (ClinicalTrials.gov)
Clinical Research in SCLC
Extending
Survival with Irinotecan and Irinotecan
Combination Regimens for SCLC (Medscape)
Discusses results of Japanese and US trials of Irinotecan (CPT-11 or Camptosar)
in SCLC patients. Examines Irinotecan combination chemotherapy. These
CME modules are aimed at physicians. Registration required for free access
to Medscape. [4/02]
Irinotecan
Highly Active in Lung Cancer (cancernetwork.com)
v.9, no. 11 (Suppl. 6) Oncology News (November 2000)
Summarizes research presented at the "Current Status of Irinotecan in
Lung Cancer" seminar held at the 9th World Conference on Lung Cancer.
Registration required for free access to cancernetwork.com. [11/00]
Camptosar
(irinotecan) Plus Cisplatin Increases Survival in Small Cell Lung Cancer
(Doctor's Guide)
Reports that Camptosar (also known as irinotecan or CPT-11) in combination
with cisplatin increased survival compared with the standard treatment
(etoposide and cisplatin) for patients with extensive small cell lung
cancer, according to a Phase III study presented at ASCO 2000. [5/00]
Irinotecan
& SCLC - Recent MEDLINE Abstracts
Irinotecan
& SCLC - Clinical Trials (ClinicalTrials.gov)
Side Effects
Irinotecan
(CancerBACUP)
Describes ifosfamide, how it is given and possible side effects.
[3/04]
Camptosar
(irinotecan) Treatment Guide (Medicine Online/Glaxo Wellcome)
Information on what to expect during treatment, possible side effects,
controlling diarrhea, and when to call the doctor. See also the Camptosar
Question
& Answer Guide. (n.b., Camptosar information given here
refers specifically to its use in the treatment of colon cancer.)
|
